Merial Sas

Other

Merial Limited

University of Saskatchewan

The Queen's University of Belfast

Gordon Moore Allan

Brian Martin Meehan

John Ellis

Catherine Elisabeth Charreyre

John R Harding

Gilles Emile Chappuis

Edward Clark

Lori Hassard

Francis McNeilly

Deborah Haines

Andrew A Potter

Lorne A Babiuk

Philip J Willson

Li Wang

George Krakowka

Jean-ChrJistophe Francis Audonnet

Jean-Christophe Francis Audonnet

George Steven Krakowka

John Albert Ellis

Brian Meehan

John Harding

The cloning of a novel PCVII viral genome is described as is expression of proteins derived from the PCVII genome. These proteins can be used in vaccine compositions for the prevention and treatment of PCVII infections, as well as in diagnostic methods for determining the presence of PCVII infections in a vertebrate subject. Polynucleotides derived from the viral genome can be used as diagnostic primers and probes.

Postweaning multisystemic wasting syndrome and porcine circovirus from pigs

Provided is a method for reducing viral load of porcine circovirus type 2 (PCV-2) in a pig by inducing an immune response against PCV-2 through the administration of an immunogenic composition comprising a PCV-2 antigen. A preferred antigen is a vector containing a PCV-2 nucleotide sequence. In a particularly preferred embodiment, the PCV-2 nucleotide sequence is ORF4, ORF13, or ORF4 and ORF13. In some embodiments, the immunogenic composition includes one or more additional pig pathogens.

Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2

The invention relates to new porcine circovirus strains isolated from pulmonary or ganglionic samples obtained from farms affected by the post-weaning multisystemic wasting syndrome (PMWS). It relates to purified preparations of these strains, conventional attenuated or inactivated vaccines, recombinant live vaccines, plasmid vaccines and subunit vaccines, as well as reagents and diagnostic methods. It also relates to the DNA fragments which can be used for the production of subunits in an in vitro expression vector or as sequences to be integrated into a virus or plasmid type in vivo expression vector.

Porcine circoviruses, vaccines and diagnostic reagents

The invention relates to antigenic preparations and vaccines directed against the porcine multisystemic wasting syndrome (PMWS), comprising at least one porcine circovirus antigen, preferably type II, and at least one porcine parvovirus antigen.

Porcine circovirus and parvovirus vaccine

Porcine circoviruses vaccines diagnostic reagents

Porcine circovirus vaccine and diagnostics reagents

Porcine circovirus and paravovirus vaccine

Growing community of inventors

Belfast, United Kingdom

Gordon Moore Allan